Searched for
GENETIC DATA SELLING
‘Nobody should be left alone with a strong drug and a printout’: After Ketto, Kunal Kapoor’s next healthcare betAfter helping families finance critical treatments through Ketto, Kunal Kapoor is now focused on preventing those medical emergencies befor...- Should they now be part of a long-term investing framework? 7 healthcare stocks with upside potential of up to 25%India’s healthcare market may grow steadily, but hospital chains can grow faster as formalisation continues. Healthcare is all about market...
- India cancels soymeal export deals, turns to Africa for soybean importsIndian traders have cancelled 25,000 metric tons of soymeal export contracts. This is the first time since 2021. They have also booked 80,0...
- For both the compulsive trader and careful investor: 25 stocks to watch if risk appetite returns; some with upside potential, some notIf the price of crude oil softens, Indian equities may again see a risk-on phase. Tariff concerns are no longer the central issue; the larg...
- Long-term Investing: Ecosystem with an edge called India; 12 large- mid- and small-cap stocks with upside potential of up to 34%Tactical investing should not be confused with long-term investing. In a world where geopolitical risk, commodity shocks, and uncertainty a...
- These large- mid- and small-cap stocks have an upside potential of up to 31% in 1 year, according to analystsAs nothing can be ruled out on the street, be prepared for anything. Now, what is the probability that the bears will be chased away from t...
- US-China talks in Beijing expose fragile balance of global powerA pivotal summit between the US and China kicks off in Beijing today. President Donald Trump's impulsive style is set to clash with Preside...
- Wealth creation is also about ignoring noise on the street: 15 mid- and small-cap stocks from different sectors which fit the billIn the April 2022-September 2024 bull market, every management appeared capable. Margins expanded, working capital looked manageable, capit...
- War, oil price hikes, and risks: Time to still be contrarian? 5 small-caps from different sectors with upside potential of up to 25%Small-cap investing is not just about finding stocks that can rise faster than the market, which is the assumption with which most investor...
- Stock picks of the week: 5 stocks with consistent score improvement and upside potential of up to 28%In these times of geopolitical stress, how will things pan out for the Indian market? Will it be a standalone underperformer? Or is it just...
- Regeneron to buy bankrupt 23andMe, vows ethical use of customer DNA dataSouth San Francisco, California-based 23andMe filed for bankruptcy last month, seeking to sell its business at auction after a decline in c...
- Genetic goldmine? Privacy crisis looms as millions of people’s DNA could be sold following 23andMe facing bankruptcy and uncertain futureDNA testing firm 23andMe has filed for bankruptcy. There are concerns about the safety of customer genetic data, with some experts advising...
- 23andMe files for Chapter 11 bankruptcy as co-founder and CEO Wojcicki resigns23andMe has filed for Chapter 11 bankruptcy, with co-founder Anne Wojcicki resigning as CEO. The company aims to sell its assets and cut co...
- Prenatal test developed with Chinese military stores gene dataThe report is the first to reveal that the company collaborated with the People's Liberation Army (PLA) to develop and improve the test, ta...
- Target of doubling farm income won't be achieved without new agri laws: Niti's Ramesh ChandThe government and unions representing farmers, who have been camping at Delhi's border for four months in protest against the three laws t...
- Who owns the virus? Coronavirus pandemic sparks debate on data sharingChina, where the novel coronavirus emerged late last year, shared the viral genetic sequence data (GSD) with the World Health Organization ...
- There’s money you can make selling your DNA. Shivom will help monetise itGenetic testing centres are selling your DNA to pharma majors to conduct drug development research without your knowledge and the latter is...
- Only Bt. Cotton is approved GM Crop: Narendra Singh TomarThere have been few incidences of suspected open cultivation of Bt. brinjal and HT cotton were reported in Maharashtra, Haryana, Punjab, Gu...
- This startup lets you cash in on your genetic dataCustomers can have their genome sequenced for under $1,000, which could then be sold to scientists or pharmaceutical manufacturers.
- As opposition to GM grows, companies are turning to mutant breedingMutagenesis isn’t new: breeders have relied on it for decades to produce thousands of varieties of lettuce, oats, rice and other crops.
Load More
